Skip to content

Stoke Therapeutics

US · STOK #2942 by market cap Listed 2019
26.81 -0.12 -0.45%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Stoke Therapeutics

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Founded
2014
CEO
Mr. Ian F. Smith
Employees
170
Headquarters
Bedford, Massachusetts, United States of America
Fiscal year end
12-31
Website
stoketherapeutics.com

Company profile

Exchange
US
Symbol
STOK
Market-cap rank
#2942
Listing date
2019-06-19
Market cap
1.75B
Float cap
1.34B
Shares out
65.41M
Float shares
49.92M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Stoke Therapeutics discussion 0 comments

Add a comment